BAYER AG TO ACQUIRE STERLING OTCs IN NORTH AMERICA FROM SMITHKLINE BEECHAM
This article was originally published in The Tan Sheet
Executive Summary
BAYER AG TO ACQUIRE STERLING OTCs IN NORTH AMERICA FROM SMITHKLINE BEECHAM for $1 bil. in a deal announced only two weeks after SmithKline cemented an agreement with Eastman Kodak to purchase Sterling Winthrop's global OTC business ("The Tan Sheet" Sept. 5, pp. 1-7). The acquisition of Sterling's North American OTC business, announced Sept. 12, ends Bayer's decades-long effort to win back its corporate name in the U.S. The German diversified pharmaceutical and chemical company was stripped of the Bayer trademark after World War I.